期刊： LEUKEMIA & LYMPHOMA, 2022; 63 (1)
Acute myeloid leukemia (AML) with t(8;21) is a heterogeneous disease and needs to be stratified. Both, cancer cells and immune cells participate in tu......
期刊： LEUKEMIA & LYMPHOMA, 2022; 63 (2)
Anti-CD19 chimeric antigen receptor (CAR) T-cell therapy has led to unprecedented results to date in relapsed/refractory (R/R) diffuse large B-cell ly......
期刊： LEUKEMIA & LYMPHOMA, 2022; 63 (7)
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease with variable outcomes. In this study, data of 84 DLBCL patients, who were tested EBV......
期刊： LEUKEMIA & LYMPHOMA, 2022; 63 (5)
Angioimmunoblastic T-cell lymphoma (AITL) is a unique sub-type of peripheral T-cell lymphoma (PTCL). We aimed to evaluate treatment programs and progn......
期刊： LEUKEMIA & LYMPHOMA, 2022; 63 (14)
This study assessed the relapse characteristics and prognosis of 145 children newly diagnosed with T-cell acute lymphoblastic leukemia (T-ALL). The ov......
期刊： LEUKEMIA & LYMPHOMA, 2022; 63 (14)
Diffuse large B-cell lymphomas (DLBCLs) are phenotypically and genetically heterogeneous. Two main subgroups of DLBCL include germinal center B-cell-l......
期刊： LEUKEMIA & LYMPHOMA, 2022; 63 (3)
The utility of circulating tumor DNA (ctDNA) in classifying the cell origin of diffuse large B-cell lymphoma (DLBCL) has not been explored in the Chin......
期刊： LEUKEMIA & LYMPHOMA, 2022; 63 (12)
Recently, the definition of primary plasma cell leukemia (pPCL) has been revised as the presence of circulating plasma cells (CPCs) >= 5% in periph......
期刊： LEUKEMIA & LYMPHOMA, 2022; 63 (13)
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematopoietic malignancy characterized by poor prognosis even following an allogeneic h......
期刊： LEUKEMIA & LYMPHOMA, 2022; 63 (9)
The physiological function and prognostic significance of C-type lectin domain family 12 member A (CLEC12A) in acute myeloid leukemia (AML) patients a......
期刊： LEUKEMIA & LYMPHOMA, 2022; 63 (2)
Non-Hodgkin lymphoma associated hemophagocytic lymphohistiocytosis (NHL-HLH) in adult secondary HLH is a common and universally highly lethal critical......
期刊： LEUKEMIA & LYMPHOMA, 2022; 63 (9)
Mixed Lineage Leukemia rearranged acute myeloid leukemia (MLLr AML) predicts a poor prognosis. Histone demethylase JMJD1C is a potential druggable tar......
期刊： LEUKEMIA & LYMPHOMA, 2022; 63 (10)
Copy number aberrations (CNA) are the core determinants for diagnosis, risk stratification and prognosis in acute myeloid leukemia (AML) and myelodysp......
